Literature DB >> 21823914

The impact of conduct disorder and stimulant medication on later substance use in an ethnically diverse sample of individuals with attention-deficit/hyperactivity disorder in childhood.

Seth C Harty1, Iliyan Ivanov, Jeffrey H Newcorn, Jeffrey M Halperin.   

Abstract

OBJECTIVE: To examine late adolescent substance use outcomes in relation to childhood conduct disorder (CD) and psychostimulant treatment in urban youth found to have attention-deficit/hyperactivity disorder (ADHD) in childhood.
METHODS: Ninety-seven adolescents, evaluated during childhood, were seen for follow-up on average 9.30 (SD = 1.65) years later along with a well-matched never-ADHD control group. Stimulant treatment history was coded: Never (n = 28), up to 1 year (n = 19), 1 to 5 years (n = 28), and greater than 5 years (n = 22). Substance use at outcome was coded dimensionally for severity (frequency × intensity) and categorically for substance use disorders (SUDs).
RESULTS: Individuals with ADHD+CD in childhood had significantly higher rates of SUD and substance use severity than those with childhood ADHD and controls. The ADHD and control groups did not differ significantly. Among those with childhood ADHD, there were no significant differences in SUD status or substance use severity as a function of medication history.
CONCLUSIONS: Within an ethnically diverse urban sample, the increased rate of substance use associated with ADHD was fully accounted for by the presence of CD. These results extend previous findings indicating little impact of psychostimulant treatment on later substance use to an ethnically diverse urban sample and to individuals who received treatment for up to 12 years.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21823914      PMCID: PMC3157746          DOI: 10.1089/cap.2010.0074

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  34 in total

Review 1.  Misunderstanding analysis of covariance.

Authors:  G A Miller; J P Chapman
Journal:  J Abnorm Psychol       Date:  2001-02

2.  Association between attention-deficit/hyperactivity disorder in adolescence and substance use disorders in adulthood.

Authors:  David W Brook; Judith S Brook; Chenshu Zhang; Jonathan Koppel
Journal:  Arch Pediatr Adolesc Med       Date:  2010-10

3.  Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers.

Authors:  H Schubiner; A Tzelepis; S Milberger; N Lockhart; M Kruger; B J Kelley; E P Schoener
Journal:  J Clin Psychiatry       Date:  2000-04       Impact factor: 4.384

4.  Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats.

Authors:  C L Brandon; M Marinelli; L K Baker; F J White
Journal:  Neuropsychopharmacology       Date:  2001-11       Impact factor: 7.853

5.  Altered responsiveness to cocaine in rats exposed to methylphenidate during development.

Authors:  Susan L Andersen; Andreas Arvanitogiannis; Andrea M Pliakas; Celeste LeBlanc; William A Carlezon
Journal:  Nat Neurosci       Date:  2002-01       Impact factor: 24.884

6.  Pathways from ADHD to early drug use.

Authors:  H D Chilcoat; N Breslau
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1999-11       Impact factor: 8.829

7.  Which aspects of ADHD are associated with tobacco use in early adolescence?

Authors:  J D Burke; R Loeber; B B Lahey
Journal:  J Child Psychol Psychiatry       Date:  2001-05       Impact factor: 8.982

8.  Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood.

Authors:  Salvatore Mannuzza; Rachel G Klein; Nhan L Truong; John L Moulton; Erica R Roizen; Kathryn H Howell; Francisco X Castellanos
Journal:  Am J Psychiatry       Date:  2008-04-01       Impact factor: 18.112

9.  Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study.

Authors:  Joseph Biederman; Michael C Monuteaux; Thomas Spencer; Timothy E Wilens; Heather A Macpherson; Stephen V Faraone
Journal:  Am J Psychiatry       Date:  2008-03-03       Impact factor: 18.112

10.  Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment.

Authors:  Elizabeth Pappadopulos; Peter S Jensen; Alanna R Chait; L Eugene Arnold; James M Swanson; Laurence L Greenhill; Lily Hechtman; Shirley Chuang; Karen C Wells; William Pelham; Thomas Cooper; Glenn Elliott; Jeffrey H Newcorn
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-05       Impact factor: 8.829

View more
  8 in total

1.  Developmental progression to early adult binge drinking and marijuana use from worsening versus stable trajectories of adolescent attention deficit/hyperactivity disorder and delinquency.

Authors:  Andrea L Howard; Brooke S G Molina; James M Swanson; Stephen P Hinshaw; Katherine A Belendiuk; Seth C Harty; L Eugene Arnold; Howard B Abikoff; Lily Hechtman; Annamarie Stehli; Laurence L Greenhill; Jeffrey H Newcorn; Timothy Wigal
Journal:  Addiction       Date:  2015-03-24       Impact factor: 6.526

Review 2.  The Impact of Pharmacotherapy of Childhood-Onset Psychiatric Disorders on the Development of Substance Use Disorders.

Authors:  Timothy E Wilens; Diana W Woodward; Je Deuk Ko; Amy F Berger; Colin Burke; Amy M Yule
Journal:  J Child Adolesc Psychopharmacol       Date:  2022-05-04       Impact factor: 3.031

3.  Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.

Authors:  Brooke S G Molina; Stephen P Hinshaw; L Eugene Arnold; James M Swanson; William E Pelham; Lily Hechtman; Betsy Hoza; Jeffery N Epstein; Timothy Wigal; Howard B Abikoff; Laurence L Greenhill; Peter S Jensen; Karen C Wells; Benedetto Vitiello; Robert D Gibbons; Andrea Howard; Patricia R Houck; Kwan Hur; Bo Lu; Sue Marcus
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-02-08       Impact factor: 8.829

4.  Predictors of treatment response in adolescents with comorbid substance use disorder and attention-deficit/hyperactivity disorder.

Authors:  Leanne Tamm; Kathlene Trello-Rishel; Paula Riggs; Paul A Nakonezny; Michelle Acosta; Genie Bailey; Theresa Winhusen
Journal:  J Subst Abuse Treat       Date:  2012-08-11

5.  Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011.

Authors:  Susanna N Visser; Melissa L Danielson; Rebecca H Bitsko; Joseph R Holbrook; Michael D Kogan; Reem M Ghandour; Ruth Perou; Stephen J Blumberg
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-11-21       Impact factor: 8.829

6.  ADHD and Marijuana-Use Expectancies in Young Adulthood.

Authors:  Seth C Harty; Sarah L Pedersen; Elizabeth M Gnagy; William E Pelham; Brooke S G Molina
Journal:  Subst Use Misuse       Date:  2015-11-07       Impact factor: 2.164

7.  Delinquency, aggression, and attention-related problem behaviors differentially predict adolescent substance use in individuals diagnosed with ADHD.

Authors:  Seth C Harty; Stavroula Galanopoulos; Jeffrey H Newcorn; Jeffrey M Halperin
Journal:  Am J Addict       Date:  2013-04-11

8.  Attention deficit/hyperactivity disorders with co-existing substance use disorder is characterized by early antisocial behaviour and poor cognitive skills.

Authors:  Berit Bihlar Muld; Jussi Jokinen; Sven Bölte; Tatja Hirvikoski
Journal:  BMC Psychiatry       Date:  2013-12-13       Impact factor: 3.630

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.